相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Successful Management of COVID-19 With Adalimumab in a Post-Coronary Artery Bypass Graft Surgery Patient
Atefeh Fakharian et al.
JOURNAL OF CARDIOTHORACIC AND VASCULAR ANESTHESIA (2022)
Differential Binding of Sarilumab and Tocilizumab to IL-6Rα and Effects of Receptor Occupancy on Clinical Parameters
Christine Xu et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2021)
Tocilizumab in Patients Hospitalized with Covid-19 Pneumonia
Carlos Salama et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Covid-19: Arthritis drugs improve survival in intensive care patients, shows study
Jacqui Wise
BMJ-BRITISH MEDICAL JOURNAL (2021)
Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention
Zunyou Wu et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
The deadly coronaviruses: The 2003 SARS pandemic and the 2020 novel coronavirus epidemic in China
Yongshi Yang et al.
JOURNAL OF AUTOIMMUNITY (2020)
Pulmonary Pathology of Early-Phase 2019 Novel Coronavirus (COVID-19) Pneumonia in Two Patients With Lung Cancer
Sufang Tian et al.
JOURNAL OF THORACIC ONCOLOGY (2020)
Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study
Nanshan Chen et al.
LANCET (2020)
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
Chaolin Huang et al.
LANCET (2020)
Preconditioning rats with three lipid emulsions prior to acute lung injury affects cytokine production and cell apoptosis in the lung and liver
Li-Mi Huang et al.
LIPIDS IN HEALTH AND DISEASE (2020)
Therapeutic options for the 2019 novel coronavirus (2019-nCoV)
Guangdi Li et al.
NATURE REVIEWS DRUG DISCOVERY (2020)
COVID-19, ACE2, and the cardiovascular consequences
Andrew M. South et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2020)
Should we stimulate or suppress immune responses in COVID-19? Cytokine and anti-cytokine interventions
Yvan Jamilloux et al.
AUTOIMMUNITY REVIEWS (2020)
Nervous system involvement after infection with COVID-19 and other coronaviruses
Yeshun Wu et al.
BRAIN BEHAVIOR AND IMMUNITY (2020)
Effectiveness of glucocorticoid therapy in patients with severe coronavirus disease 2019: protocol of a randomized controlled trial
Yuan-Yuan Qin et al.
CHINESE MEDICAL JOURNAL (2020)
Potential effect of blood purification therapy in reducing cytokine storm as a late complication of critically ill COVID-19
Jie Ma et al.
CLINICAL IMMUNOLOGY (2020)
The use of anti-inflammatory drugs in the treatment of people with severe coronavirus disease 2019 (COVID-19): The Perspectives of clinical immunologists from China
Wen Zhang et al.
CLINICAL IMMUNOLOGY (2020)
Cytokine storm in COVID-19: pathogenesis and overview of anti-inflammatory agents used in treatment
Mehmet Soy et al.
CLINICAL RHEUMATOLOGY (2020)
Pathological findings of COVID-19 associated with acute respiratory distress syndrome
Zhe Xu et al.
LANCET RESPIRATORY MEDICINE (2020)
Cytokine release syndrome in severe COVID-19: interleukin-6 receptor antagonist tocilizumab may be the key to reduce mortality
Chi Zhang et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2020)
Effective treatment of severe COVID-19 patients with tocilizumab
Xiaoling Xu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
Clinical, laboratory and imaging features of COVID-19: A systematic review and meta-analysis
Alfonso J. Rodriguez-Morales et al.
TRAVEL MEDICINE AND INFECTIOUS DISEASE (2020)
New therapeutic opportunities for COVID-19 patients with Tocilizumab: Possible correlation of interleukin-6 receptor inhibitors with osteonecrosis of the jaws
Francesco Bennardo et al.
ORAL ONCOLOGY (2020)
Neutrophil Extracellular Traps (NETs) and Damage-Associated Molecular Patterns (DAMPs): Two Potential Targets for COVID-19 Treatment
Sebastiano Cicco et al.
MEDIATORS OF INFLAMMATION (2020)
Early IL-1 receptor blockade in severe inflammatory respiratory failure complicating COVID-19
Raphael Cauchois et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
Efficacy of Tocilizumab in Patients Hospitalized with Covid-19
John H. Stone et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Blockage of interleukin-1β with canakinumab in patients with Covid-19
Lorenza Landi et al.
SCIENTIFIC REPORTS (2020)
COVID-19 Infection in a Patient with End-Stage Kidney Disease
Dian Fu et al.
NEPHRON (2020)
The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak - an update on the status
Yan-Rong Guo et al.
MILITARY MEDICAL RESEARCH (2020)
Mitochondria: the indispensable players in innate immunity and guardians of the inflammatory response
Abhishek Mohanty et al.
JOURNAL OF CELL COMMUNICATION AND SIGNALING (2019)
The NLRP3 Inflammasome: An Overview of Mechanisms of Activation and Regulation
Nathan Kelley et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Innate immune memory: An evolutionary perspective
Benjamin Gourbal et al.
IMMUNOLOGICAL REVIEWS (2018)
Melatonin: A Versatile Protector against Oxidative DNA Damage
Annia Galano et al.
MOLECULES (2018)
Mitochondria in innate immune signaling
Balaji Banoth et al.
TRANSLATIONAL RESEARCH (2018)
Molecular mechanisms and functions of pyroptosis, inflammatory caspases and inflammasomes in infectious diseases
Si Ming Man et al.
IMMUNOLOGICAL REVIEWS (2017)
Clarifying the supercomplex: the higher-order organization of the mitochondrial electron transport chain
James A. Letts et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2017)
Clarifying the supercomplex: the higher-order organization of the mitochondrial electron transport chain
James A. Letts et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2017)
Melatonin transport into mitochondria
Juan C. Mayo et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2017)
Mitochondrial DNA in innate immune responses and inflammatory pathology
A. Phillip West et al.
NATURE REVIEWS IMMUNOLOGY (2017)
Mitochondria as a centrally positioned hub in the innate immune response
Rajat Sandhir et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2017)
Identification of Nafamostat as a Potent Inhibitor of Middle East Respiratory Syndrome Coronavirus S Protein-Mediated Membrane Fusion Using the Split-Protein-Based Cell-Cell Fusion Assay
Mizuki Yamamoto et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2016)
Interleukin-1 Receptor Blockade Is Associated With Reduced Mortality in Sepsis Patients With Features of Macrophage Activation Syndrome: Reanalysis of a Prior Phase III Trial
Bita Shakoory et al.
CRITICAL CARE MEDICINE (2016)
Macrophage Activation Syndrome in Patients with Systemic Juvenile Idiopathic Arthritis under Treatment with Tocilizumab
Shumpei Yokota et al.
JOURNAL OF RHEUMATOLOGY (2015)
Sarilumab, a fully human monoclonal antibody against IL-6Rα in patients with rheumatoid arthritis and an inadequate response to methotrexate: efficacy and safety results from the randomised SARIL-RA-MOBILITY Part A trial
Tom W. J. Huizinga et al.
ANNALS OF THE RHEUMATIC DISEASES (2014)
Advances in understanding the pathogenesis of HLH
G. Naheed Usmani et al.
BRITISH JOURNAL OF HAEMATOLOGY (2013)
Melatonin: its possible role in the management of viral infections-a brief review
Michela Silvestri et al.
ITALIAN JOURNAL OF PEDIATRICS (2013)
Fluid overload and fluid removal in pediatric patients on extracorporeal membrane oxygenation requiring continuous renal replacement therapy
David T. Selewski et al.
CRITICAL CARE MEDICINE (2012)
Efficacy and safety of tocilizumab in patients with systemic-onset juvenile idiopathic arthritis: a randomised, double-blind, placebo-controlled, withdrawal phase III trial
Shumpei Yokota et al.
LANCET (2008)
STING is an endoplasmic reticulum adaptor that facilitates innate immune signalling
Hiroki Ishikawa et al.
NATURE (2008)
Cell type-specific involvement of RIG-I in antiviral response
H Kato et al.
IMMUNITY (2005)
Endogenously oxidized mitochondrial DNA induces in vivo and in vitro inflammatory responses
LV Collins et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2004)
Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus
WH Li et al.
NATURE (2003)
分享论文
